Table 2.
Characteristics of participants with and without NAFLD by EVOO oil categories. MICOL/PANEL Study. Castellana Grotte. (BA), Italy (2005-2022).
| with NAFLD | without NAFLD | |||||||
|---|---|---|---|---|---|---|---|---|
| EVOO Categories (g/Die) | EVOO Categories (g/Die) | |||||||
| <20 | 21–30 | 31–40 | >40 | <20 | 21–30 | 31–40 | >40 | |
| N | 188 | 182 | 177 | 231 | 402 | 371 | 335 | 505 |
| Gender ** | ||||||||
| Female | 57 (21.4) | 63 (23.7) | 65 (24.4) | 81 (30.5) | 236 (28.8) | 198 (24.1) | 158 (19.3) | 228 (27.8) |
| Male | 131 (25.6) | 119 (23.2) | 112 (21.9) | 150 (29.3) | 166 (20.9) | 173 (21.8) | 177 (22.3) | 277 (34.9) |
| Age enrolment (yrs) | 46.80 (12.57) | 52.60 (12.40) | 55.79 (12.62) | 61.57 (13.16) | 45.50 (13.33) | 51.31 (15.12) | 55.47 (16.22) | 61.21 (14.28) |
| DBP (mmHg) * | 121.95 (18.18) | 125.05 (18.16) | 128.85 (18.50) | 131.16 (19.09) | 112.86 (18.10) | 118.82 (19.01) | 121.36 (18.91) | 128.00 (20.32) |
| SBP (mmHg) * | 76.85 (10.30) | 77.41 (12.32) | 78.15 (9.58) | 76.89 (9.99) | 71.08 (9.67) | 73.22 (10.04) | 73.40 (9.74) | 74.55 (9.53) |
| Weight (kg) * | 85.13 (14.68) | 83.24 (14.46) | 83.96 (16.52) | 83.96 (16.04) | 68.64 (12.76) | 69.09 (12.34) | 69.87 (12.50) | 70.74 (13.36) |
| BMI (kg/m2) * | 31.12 (4.60) | 31.41 (4.82) | 31.91 (5.49) | 32.23 (5.68) | 25.78 (3.99) | 26.41 (3.90) | 26.90 (4.29) | 27.80 (4.68) |
| Kcal days * | 1986.8 (723.6) | 2185.4 (762.0) | 2144.6 (726.1) | 2299.0 (683.3) | 2031.0 (680.3) | 2117.7 (708.4) | 2215.1 (680.5) | 2340.4 (685.7) |
| TGL (mmol/L) * | 1.87 (1.40) | 1.88 (1.34) | 1.90 (1.19) | 1.85 (1.08) | 1.11 (0.70) | 1.17 (0.87) | 1.16 (0.67) | 1.26 (0.73) |
| TC (mmol/L) * | 5.27 (0.96) | 5.27 (1.16) | 5.30 (1.02) | 5.25 (0.93) | 5.06 (0.89) | 5.04 (0.97) | 5.07 (0.97) | 5.07 (0.98) |
| HDL (mmol/L) * | 1.16 (0.28) | 1.18 (0.29) | 1.18 (0.28) | 1.23 (0.27) | 1.41 (0.38) | 1.40 (0.40) | 1.37 (0.36) | 1.40 (0.38) |
| LDL (mmol/L) * | 3.30 (0.82) | 3.24 (1.09) | 3.26 (0.81) | 3.18 (0.83) | 3.14 (0.76) | 3.10 (0.86) | 3.17 (0.86) | 3.08 (0.83) |
| Glucose (mmol/L) * | 6.26 (1.75) | 6.22 (1.32) | 6.34 (1.67) | 6.52 (1.71) | 5.62 (0.85) | 5.85 (1.31) | 5.80 (1.36) | 5.89 (1.27) |
| AST (μkat/L) * | 0.35 (0.18) | 0.36 (0.25) | 0.31 (0.14) | 0.30 (0.18) | 0.24 (0.13) | 0.24 (0.25) | 0.27 (0.25) | 0.28 (0.34) |
| ALT (μkat/L) * | 0.21 (0.13) | 0.22 (0.10) | 0.21 (0.08) | 0.21 (0.09) | 0.18 (0.07) | 0.19 (0.10) | 0.21 (0.16) | 0.23 (0.25) |
| Status *** | ||||||||
| Alive and/or Censored | 165 (27.5) | 145 (24.2) | 141 (23.5) | 149 (24.8) | 352 (28.6) | 307 (24.9) | 243 (19.7) | 329 (26.7) |
| Dead | 23 (12.9) | 37 (20.8) | 36 (20.2) | 82 (46.1) | 50 (13.1) | 64 (16.8) | 92 (24.1) | 176 (46.1) |
| rMED | 8 (6–9) | 8 (6–9) | 8 (7–10) | 9 (7–10) | 7 (6–9) | 8 (6–10) | 8 (7–10) | 8 (8–10) |
AST: Aspartate Transaminase ALT: Alanine Amino transferase; BMI: Body Mass Index; DBP: Diastolic Blood Pressure; SBP: Systolic Blood Pressure; TGL: Triglycerides; TC: Total Cholesterol; HDL: High-Density Lipoprotein Cholesterol; LDL: Low-Density Lipoprotein Cholesterol; rMED: relative Mediterranean Scoring System. Cells reporting subject characteristics contain * Mean ± (SD). ** Median (IQR). *** Number. (Percentage) Percentage calculated per row.